|
北京昭衍新藥研究中心股份有限公司– H股, 06127.HK - 綜合資產負債表 |
2023-12 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
固定資產 |
1,303,491 |
1,234,691 |
814,728 |
645,871 |
576,320 |
409,150 |
317,653 |
投資 |
767,153 |
667,241 |
130,950 |
64,445 |
12,000 |
0 |
0 |
流動資產 |
7,121,967 |
5,928,406 |
5,814,484 |
1,182,687 |
715,919 |
714,502 |
619,927 |
其他資產 |
834,548 |
2,533,878 |
1,776,915 |
279,899 |
265,902 |
53,324 |
36,546 |
總資產 |
10,027,159 |
10,364,216 |
8,537,077 |
2,172,902 |
1,570,141 |
1,176,976 |
974,126 |
長期債項 |
41,925 |
60,168 |
69,127 |
74,545 |
64,557 |
2,213 |
0 |
其他長期負債 |
236,828 |
268,920 |
109,272 |
102,241 |
101,588 |
82,837 |
74,465 |
流動負債 |
1,467,365 |
1,844,262 |
1,214,242 |
774,307 |
554,051 |
424,506 |
323,106 |
股本 |
749,889 |
535,679 |
381,246 |
227,455 |
161,717 |
114,995 |
81,800 |
儲備 |
7,529,427 |
7,648,022 |
6,754,968 |
995,089 |
687,483 |
552,224 |
494,403 |
股東權益 |
8,279,316 |
8,183,701 |
7,136,214 |
1,222,544 |
849,200 |
667,219 |
576,203 |
貨幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
單位 |
主要項目 |
存貨 |
184,593 |
350,182 |
106,293 |
91,011 |
49,555 |
12,969 |
10,338 |
現金及銀行結存 |
2,862,912 |
2,916,848 |
4,154,099 |
308,690 |
176,958 |
148,693 |
254,617 |
短期債項 |
27,500 |
27,539 |
26,195 |
17,601 |
25,622 |
693 |
0 |
總債項 |
69,425 |
87,707 |
95,322 |
92,146 |
90,179 |
2,906 |
0 |
核數師意見 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|